Heron

US Business Development success

The US Business Development team has been very successful building new relationships across the US. As a result of these activities, HERON is now working with 4 new clients to the company.

In Q4 2008, HERON US has won the following new projects:

Finally, our reputation as a leader in MS, after the unprecedented outcome of the NICE submission for Natalizumab in Highly Active RRMS, will be further underscored by a number of new projects we will be undertaking for MS drugs in development.